Not applicableStudy completedNCT02441166What this trial is testingDiagnostic Value of Bone Marrow Tryptase in Systemic MastocytosisWho this might be right forSystemic Mastocytosis University Hospital, Toulouse 250
Large-scale testing (Phase 3)UnknownNCT05084872What this trial is testingHydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement PatientsWho this might be right forMastocytosis University Hospital, Toulouse 30
Large-scale testing (Phase 3)Study completedNCT03401060What this trial is testingInterest of Denosumab Treatment in Osteoporosis Associated to Systemic MastocytosisWho this might be right forOsteoporosisSystemic Mastocytosis Assistance Publique - Hôpitaux de Paris 24
Early research (Phase 1)Study completedNCT02808793What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002Who this might be right forIndolent Systemic Mastocytosis Allakos Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00154388What this trial is testingPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesWho this might be right forLife Threatening Diseases Novartis Pharmaceuticals 185
Early research (Phase 1)Looking for participantsNCT05362773What this trial is testingMGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forLeukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more MacroGenics 130
Early research (Phase 1)Ended earlyNCT05609942What this trial is testingStudy of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic MalignanciesWho this might be right forAdvanced Systemic Mastocytosis Blueprint Medicines Corporation 9
Not applicableStudy completedNCT04695431What this trial is testingRetrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSMWho this might be right forAdvanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematological Neoplasm+1 more Blueprint Medicines Corporation 317
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Not applicableWithdrawnNCT02450396What this trial is testingPregnancy and Medically Assisted Conception in Rare DiseasesWho this might be right forRheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+8 more Assistance Publique - Hôpitaux de Paris
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Testing effectiveness (Phase 2)UnknownNCT01920204What this trial is testingMidostaurin in Indolent Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis University Medical Center Groningen 20
Testing effectiveness (Phase 2)Study completedNCT00416624What this trial is testingEpoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 239
Large-scale testing (Phase 3)Study completedNCT00814073What this trial is testingMasitinib in Severe Indolent or Smoldering Systemic MastocytosisWho this might be right forIndolent Systemic Mastocytosis AB Science 135
Testing effectiveness (Phase 2)Study completedNCT02478957What this trial is testingTreatment of Indolent Systemic Mastocytosis With PA101Who this might be right forMastocytosisSystemic MastocytosisIndolent Systemic Mastocytosis Patara Pharma 41
Not applicableLooking for participantsNCT07255638What this trial is testingA Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in GermanyWho this might be right forIndolent Systemic Mastocytosis Blueprint Medicines Corporation 80
Testing effectiveness (Phase 2)Study completedNCT00171912What this trial is testingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesWho this might be right forHypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more Novartis Pharmaceuticals 38